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ARTICLE
The nucleophilic amino group of lysine is central
for histone lysine methyltransferase catalysis
Abbas H.K. Al Temimi1, Helene I.V. Amatdjais-Groenen 1, Y. Vijayendar Reddy1, Richard H. Blaauw2,
Hong Guo3,4, Ping Qian5 & Jasmin Mecinović 1,6
Histone lysine methyltransferases (KMTs) are biomedically important epigenetic enzymes
that catalyze the transfer of methyl group from S-adenosylmethionine to lysine’s nucleophilic
ε-amino group in histone tails and core histones. Understanding the chemical basis of KMT
catalysis is important for discerning its complex biology in disease, structure-function rela-
tionship, and for designing speciﬁc inhibitors with therapeutic potential. Here we examine
histone peptides, which possess simplest lysine analogs with different nucleophilic character,
as substrates for human KMTs. Combined MALDI-TOF MS experiments, NMR analyses and
molecular dynamics and free-energy simulations based on quantum mechanics/molecular
mechanics (QM/MM) potential provide experimental and theoretical evidence that KMTs do
have an ability to catalyze methylation of primary amine-containing N-nucleophiles, but do
not methylate related amide/guanidine-containing N-nucleophiles as well as simple O- and
C-nucleophiles. The results demonstrate a broader, but still limited, substrate scope for KMT
catalysis, and contribute to rational design of selective epigenetic inhibitors.
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H istone proteins undergo numerous posttranslationalmodiﬁcations, which lead to a dynamic and complexepigenetic landscape that regulates the activity of genes in
humans and other eukaryotes1–3. Nε-methylation of lysine resi-
dues has been found on unstructured N-terminal histone tails as
well as on core histones, and could lead to transcriptional acti-
vation or repression, depending on the locations of methylated
lysine residues and methylation states4–7. As established for most
histone posttranslational modiﬁcations, lysine methylation is a
dynamic process that is regulated by three classes of epigenetic
proteins, i.e., histone lysine methyltransferases (KMTs), histone
lysine demethylases (KDMs), and Nε-methyl lysine binding epi-
genetic proteins1. Histone Nε-lysine methylation is catalyzed by
S-adenosylmethionine (SAM)-dependent histone lysine methyl-
transferases, which also catalyze the methylation of many
non-histone proteins of biomedical importance (Fig. 1a)8. KMT-
catalyzed methylation of lysine residues can produce mono-
methyllysine (Kme), dimethyllysine (Kme2), and trimethyllysine
(Kme3) residues with an unaltered positive charge and an
increased hydrophobicity (Fig. 1a)5,9,10. With the exception of
DOT1L, all characterized KMTs contain a highly conserved SET
(Su(var)3-9, enhancer-of-zeste, trithorax) domain, which is
essential for the enzymatic activity8,11.
Mechanistic and structural studies revealed basic molecular
requirements for KMT-catalyzed Nε-lysine methylation of his-
tones and other proteins8,11–16. Binding of SAM cosubstrate to a
methyltransferase proceeds before histone substrate association,
which induces a signiﬁcant conformational change of the post-
SET (located at the C terminus of SET) domain. Upon the for-
mation of the tertiary complex, the lysine side chain occupies a
narrow, hydrophobic channel, most often comprised of side
chains of Phe and Tyr residues (Fig. 1b, c). The nucleophilic ε-
amino group of lysine is positioned toward the electrophilic
methyl group of SAM (Fig. 1b, c). Although lysine exists in a
protonated form at physiological conditions, an active-site Tyr or
a water channel have been proposed to act as a general base for
deprotonation of the ammonium ion of lysine, thus leading to a
neutral form of lysine with a strong nucleophilic character17,18.
Examinations of the active-site variants demonstrated that Phe
and Tyr residues control the ﬁnal methylation state of lysine15.
Kinetic isotope measurements provided evidence that the transfer
of the methyl group from SAM to Nε-lysine takes place via the
SN2 reaction19,20.
To understand the mechanism of KMT-catalyzed SAM-
dependent methylation of lysine residues at an unprecedent level
of detail, recent work explored the KMT active-site residues that
possibly play an important role in enzymatic catalysis15. More-
over, examinations of sterically demanding SAM analogs as
cosubstrates for recombinantly expressed KMTs, and in cellular
assays showed that KMTs not only catalyze the methylation
reaction, but also related alkylation reactions21–23. At present,
however, it is still unknown whether KMTs do have an ability to
catalyze methylation of lysine analogs that possess nucleophilic
groups other than the Nε amino group. Here we report integrated
experimental and computational studies on human KMT-
catalyzed methylation of the simplest lysine analogs that possess
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Fig. 1 Histone lysine methyltransferase-catalyzed methylation of lysine. a Methylation of lysine residue by histone lysine methyltransferases using SAM as
a methyl donor. b View on the crystal structure of SETD8 with H4K20 peptide (magenta) and SAH (yellow). c View on the crystal structure of GLP with
H3K9me peptide (magenta) and SAH (yellow). d Unnatural lysine analogs possessing functionalities with a different nucleophilic character
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N-, O-, and C-nucleophiles (Fig. 1d). The results demonstrate
that, whereas O- and C-nucleophiles are not methylated, some of
the N-nucleophiles can be substrates for KMTs.
Results
Selection of lysine analogs. Lysine’s structural elements comprise
L-stereochemistry, four methylene groups, and the nucleophilic
and basic Nε amino group at the end of the side chain. Our recent
studies demonstrated that the L-stereochemistry, the chain length,
and the main chain all determine a degree of KMT-catalyzed
methylation, highlighting that lysine possesses the optimal
L-conﬁguration and the length of side chain for efﬁcient KMT-
catalyzed methylation24–27. The central question that needs to be
addressed concerns the importance of the nucleophilic character
of lysine’s Nε amino group for KMT catalysis. Therefore, deter-
mination of the effects on the methyl transfer due to simplest
chemical perturbations on the lysine’s side chain, while main-
taining the L-conﬁguration and the same chain length, would
advance our fundamental understanding of KMT catalysis and
form the basis for designing chemical probes for KMTs. Our
panel of lysine analogs includes: (i) Primary N-nucleophiles Kaza
and Koxy; (b) Resonance-stabilized N-nucleophiles hGln and
nArg; (c) O-nucleophiles KOH and KCOOH; and (d) C-
nucleophiles Kalkyne and Kalkene (Fig. 1d).
The synthesis of the required building block Fmoc-Kaza(Boc)2-
OH 1 was based on an established protocol (Fig. 2)28.
Perbenzylation of L-glutamic acid 9 to intermediate 10, followed
by selective DIBAL-H-mediated reduction of the side chain ester
to alcohol afforded 11 in 87% yield. Subsequently, Swern
oxidation furnished the corresponding amino aldehyde 12, which
was then treated with tert-butylcarbazate to give the intermediate
hydrazone 13 in excellent 93% yield. Next, sodium cyanobor-
ohydride was used to reduce hydrazone to hydrazide 14 in 87%
yield. The synthesis was continued with the Boc-protection of the
ε-nitrogen yielding compound 15, deprotection of benzyl groups,
and a ﬁnal Fmoc-protection to generate the appropriate
unnatural building block 1 (77% yield in two steps). The
synthetic route for the preparation of Fmoc-Koxy(Boc)-OH 2
followed the same ﬁrst two steps as for 1, according to previously
described protocol (Fig. 2)29. The preparation of the
hydroxylamine-containing amino acid proceeded through the
activation of alcohol with N-hydroxyphthalimide employing
Mitsunobu reaction to give compound 16. Deprotection of the
phthalimide to produce a benzylated oxylysine, followed by
installation of Boc group afforded 17 in 93% yield. Removal of the
benzyl groups, followed by direct Fmoc-protection at the α-amino
group, yielded the ﬁnal Fmoc-Koxy(Boc)-OH 2 in 66% yield.
Benzylation of carboxylic group of Fmoc-allylglycine-OH 18,
followed by oleﬁn cross metathesis with allyl-tert-butyl ether,
produced alkene 19 in 41% yield. A subsequent hydrogenation
step furnished the novel unnatural building block 3 in 48% yield.
Similarly, the synthesis of the compound 4 was accomplished in
three steps from 18 (Fig. 2). Benzylation of carboxylic acid 18,
followed by the cross metathesis of the allyl side chain with tert-
butyl acrylate yielded product 20. Subsequently, reduction of the
resulting alkene via catalytic hydrogenation with the concomitant
generation of the free acid liberated the building block 4 in
excellent 87% yield. The building blocks 5, 6, 7, and 8 were
commercially available.
To examine whether the unnatural amino acids are methylated
by human KMTs, histone peptides that contain the above eight
lysine analogs (Fig. 1d) were synthesized by solid-phase peptide
synthesis (SPPS) (H4 residues 13–27, GGAKRHRX20VLRDNIQ;
H3 residues 1–15, ARTKQTARX9STGGKA). We also synthe-
sized 15-mer H4K20me for NMR studies and 14-mer H3K9 for
competition experiments in MALDI-TOF MS studies. All histone
peptides were obtained in high purity by preparative HPLC, and
all puriﬁed histone peptides were further examined by analytical
HPLC and ESI–MS (Supplementary Figs. 1–12 and Supplemen-
tary Tables 1 and 2).
Examining KMT-catalyzed methylation by MALDI-TOF MS.
Histone peptides that bear lysine and its unnatural analogs were
examined as substrates for KMTs employing MALDI-TOF MS
assays. We previously established the standard conditions at
which the natural histone sequences are efﬁciently methylated by
various human KMTs24. At standard conditions, a mixture of
KMT enzyme (2 µM), H3/H4 histone peptide (100 µM), SAM
(200 μM for monomethylation and 500 μM for trimethylation),
buffered in 50 mM Tris at pH 8.0 was incubated for 1 h at 37 °C,
and then examined by MALDI-TOF MS. SETD8 (SET domain
containing lysine methyltransferase 8) catalyzed almost quanti-
tative monomethylation of H4K20 (Fig. 3a, top panel, and Sup-
plementary Fig. 13), whereas G9a and GLP (G9a-Like Protein)
catalyzed the predominant formation of H3K9me3 (Fig. 3b, c, top
panels, and Supplementary Figs. 14 and 15). Initially, we exam-
ined whether SETD8 could catalyze the methylation of the
H4Kaza20 and H4Koxy20 peptides. In the presence of SETD8 and
SAM, these two peptides underwent quantitative mono-
methylatation (H4Kaza20me and H4Koxy20me), similar to the
H4K20 peptide (Fig. 3a and Supplementary Fig. 13). To verify
that the formation of monomethylated species is due to the
enzyme activity in the presence of SAM, control experiments
were carried out in the absence of SETD8 and SAM with both
unnatural substrates. As expected, the results manifested that no
detectable methylation was observed (Supplementary Figs. 16 and
17). Enzyme kinetics analyses revealed that H4K20, H4Kaza20 and
H4Koxy20 exhibit similar kinetic parameters for SETD8-catalyzed
methylation reactions (Supplementary Fig. 18). Measured sub-
strate efﬁciencies (kcat/Km) were: 38.5 mM−1 min−1 for H4K20,
38.9 mM−1 min−1 for H4Kaza20, and 30.3 mM−1 min−1 for
H4Koxy20 (Table 1). Both kcat values (4.14–4.89 min−1) and Km
values (114–137 μM) were comparable for H4K20, H4Kaza20, and
H4Koxy20, indicating similar substrate binding afﬁnity and efﬁ-
ciency of the methyl transfer reaction (Table 1). We subsequently
screened the remaining six peptides as possible substrates for
SETD8 (Supplementary Fig. 19). H4nArg20 (positively charged)
and H4hGln20 (neutral) did not undergo SETD8-catalyzed
methylation within limits of detection (<5%), demonstrating
that not all N-nucleophiles act as substrates for KMTs. Next,
enzymatic reactions were undertaken to determine whether the
replacement of the positively charged Nε-amino group of lysine
by simplest O-nucleophiles (i.e., –OH and –COOH) leads to
SETD8-catalyzed methylation. Nevertheless, no O-methylation
was detected within detection limits by MALDI–MS. Similarly,
the electron-rich triple and double bonds did not react with SAM
in the presence of SETD8. Moreover, a prolonged incubation (1
and 5 h) in the presence of high concentration of SETD8 (10 µM)
and SAM (1 mM) also did not lead to observable formation of
methylated products (Supplementary Figs. 20 and 21).
Table 1 Kinetic parameters for SETD8-catalyzed methylation
of H4K20, H4Kaza20, and H4Koxy20
kcat (min−1) Km (μM) kcat/Km (mM−1 min−1)
H4K20 4.89 ± 0.59 127 ± 16 38.5
H4Kaza20 4.43 ± 0.56 114 ± 16 38.9
H4Koxy20 4.14 ± 0.74 137 ± 25 30.3
Values obtained from three to ﬁve repeated experiments (errors deﬁned as s.d.)
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Attention was then focused on the examination of H3Kaza9 and
H3Koxy9 as possible substrates for G9a and GLP. Strikingly,
H3Kaza9 underwent predominant formation of trimethylated
product H3Kaza9me3 in the presence of G9a; the same
methylation level was observed with the natural H3K9 forming
H3K9me3 under standard conditions (Fig. 3b, c, middle panels,
and Supplementary Figs. 14 and 15). Lowering the concentration
of G9a (200 and 500 nM) also resulted to the formation of higher
methylation states of lysine and its analogs (Supplementary
Figs. 22 and 23). Incubation for 1 h at high concentrations of G9a
or GLP (10 µM) and SAM (2mM) led to nearly quantitative
formation of trimethylated species H3Kaza9me3 (Supplementary
Figs. 24 and 25). Remarkably, H3Koxy9 underwent GLP/G9a-
catalyzed methylation to produce H3Koxy9me2 as a main product
under standard conditions (Fig. 3b, c, bottom panels, and
Supplementary Figs. 18 and 19). Longer incubation times (1
and 5 h) using additional G9a or GLP (10 µM) and SAM (2mM)
still afforded only H3Koxy9me2, not forming signiﬁcant amounts
of H3Koxy9me3 (Supplementary Fig. 26). Control experiments in
the absence of G9a/GLP and SAM with H3Kaza9 and H3Koxy9
peptides showed that no methylation was detected (Supplemen-
tary Figs. 27–30). Given the ability of both G9a and GLP to
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Fig. 2 Synthesis of Fmoc-protected lysine analogs. a (i) BnBr, K2CO3, NaOH, H2O, reﬂux, 2.5 h, 50%; (ii) DIBAL-H,THF, 0 °C, 1 h, Ar, 87%; (iii) Swern
oxidation, −78 °C, 1 h, 88%; (iv) tert-butylcarbazate, HF, 16 h, rt, 93%; (v) NaBH3CN, p-TsOH, rt, 30mins, 87%; (vi) Boc2O, Et3N, DCM, rt, 16 h, 80%; (vii)
Pd/C, MeOH, H2 (1 atm), rt, 16 h; (viii) Fmoc-OSu, K2CO3, dioxane/water, 0 °C, 6 h, 77%; (ix) DEAD, Ph3P, N-hydroxyphthalimide, THF, 5 h, 85% (two
steps); (x) NH2OH, DCM, 0 °C; (xi) Boc2O, Et3N, THF, rt, 16 h, 93% (two steps); (xii) Pd/C, MeOH, H2 (atm), rt, 16 h; (xiii) Fmoc-OSu, NaHCO3, dioxane/
water, 0 °C, 2.5 h, 66% (two steps). b (xiv) BnBr, NaHCO3, DMF, rt, N2 (1 atm), 16 h, 57%; (xv) 10mol% HGII, allyl-tert-butyl ether, DCM, reﬂux, 16 h, 41%;
(xvi) Pd/C, H2 (1 atm), EtOH, 12 h, 48%. c (xvii) BnBr, NaHCO3, DMF, rt, N2 (1 atm), 16 h, 57%; (xviii) 5 mol% HGII, tert-butyl acrylate, DCM, reﬂux, 2 h,
82%; (xix) Pd/C, H2 (1 atm), EtOH, 1 h, 87%
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Fig. 3 KMTs catalyze methylation of lysine, azalysine, and oxylysine. a MALDI-TOF MS showing methylation of H4K20 (top panel), H4Kaza20 (middle
panel), and H4Koxy20 (bottom panel) peptide in the presence of SETD8 and SAM. b MALDI-TOF MS showing methylation of H3K9 (top panel), H3Kaza9
(middle panel), and H3Koxy9 (bottom panel) peptide in the presence of G9a and SAM. c MALDI-TOF MS showing methylation of H3K9 (top panel),
H3Kaza9 (middle panel), and H3Koxy9 (bottom panel) peptide in the presence of GLP and SAM
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catalyze trimethylation of azalysine and dimethylation of
oxylysine, we next sought to examine H3hGln9, H3nArg9,
H3KOH9, H3KCOOH9, H3Kalkyne9, and H3Kalkene9 as possible
substrates for G9a and GLP. G9a and GLP displayed no activity
for the tested peptides under standard conditions (Supplementary
Figs. 31 and 32), as well as upon prolonged incubation with
additional G9a/GLP and SAM (Supplementary Figs. 33–36).
Competition studies were then carried out to determine
whether the eight lysine analogs that display different nucleo-
philic character do inhibit G9a-catalyzed trimethylation of the 14-
mer H3K9 peptide. The examination was performed in the
presence of equimolar amounts of each of 15-mer histone
peptides that possess unnatural lysine analogs and the 14-mer
H3K9 natural sequence. The degree of methylation of 14-mer
H3K9 during the competition experiments was compared to a
control sample in the absence of competing peptide. Experiments
revealed that all these analogs were able to bind the active site of
G9a, thus leading to a partial inhibition G9a, as manifested by a
reduced intensity of 14-mer H3K9me3 and increased intensities
of H3K9me2 and H3K9me, and in some cases H3K9 signals
(Supplementary Figs. 37–40). Following these competition
experiments, we carried out additional inhibition studies aimed
at providing IC50 values. All unmethylated histone peptides were
screened for inhibition at 100 µM concentration in the presence
of G9a or GLP (100 nM), SAM (20 µM) and 14-mer H3K9
peptide (5 µM) in glycine assay buffer pH 8.8 at 37 °C for 35 min.
The initial rates of 14-mer peptide trimethylation in the samples
were compared to a control sample in the absence of
unmethylated histone peptides. MALDI-TOF MS data showed
no signiﬁcant (IC50 > 100 µM) inhibition of 14-mer H3K9 peptide
trimethylation by the unnatural histone peptides within the
examined range (Supplementary Figs. 41–43). Among the panel
of histone peptides, H3hGln9 was observed to be the most potent
inhibitor of G9a and GLP. A dose–response curve revealed that
the H3hGln9 peptide inhibits G9a-catalyzed methylation of
H3K9, with IC50 values of 88.8 and 76.0 µM for G9a and GLP,
respectively.
Examining KMT-catalyzed methylation by NMR spectroscopy.
After investigating the methylation of different nucleophilic ana-
logs of lysine in the presence of SETD8, G9a, and GLP, we then
carried out detailed NMR studies to provide additional informa-
tion about the level and site of methylation. Before NMR analysis
of SETD8- and G9a-catalyzed methylation of lysine analogs, all
synthetic peptides were fully characterized by 1D and 2D NMR
analyses (Supplementary Figs. 44–49). 1H NMR spectrum of
reaction mixture that contains the H4K20 peptide (400 μM), SAM
(2mM), and SETD8 (8 μM) in Tris-D11 buffer (50mM, pD 8.0)
showed a downﬁeld shift for the CH2ε (2.94 ppm) of K20, a
characteristic new singlet (2.62 ppm) for NMe, and a triplet for
SAH (2.61 ppm) (Fig. 4a and Supplementary Fig. 50). This result
is consistent with previously reported data on SETD7-catalyzed
monomethylation of H3K4 (ref. 30). The Heteronuclear Single
Quantum Coherence (HSQC) NMR experiment showed that
chemical shifts change upon the installation of the methyl group
on Nε. 1H NMR resonance at 2.94 ppm (13C: 48.3 ppm) is lysine
CH2ε, and the 1H resonance at 2.62 ppm (13C: 32.0 ppm) is lysine
NMe (Fig. 4d); these results were further supplemented with Total
Correlated Spectroscopy (TOCSY) and Heteronuclear Multiple
Bond Correlation HMBC analyses (Supplementary Fig. 51). To
provide unambiguous evidence for the methylation of H4K20 by
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Fig. 4 NMR analyses of SETD8-catalyzed methylation. a 1H NMR data and the assignment of indicative resonances of the SETD8-catalyzed
monomethylation of H4K20 in the presence of SAM after 1 h at 37 °C. b 1H NMR data of the SETD8-catalyzed monomethylation of H4Kaza20. c 1H NMR
data of the SETD8-catalyzed monomethylation of H4Koxy20. The zoomed areas are shown in dotted box. d 1H-13C HSQC data of the enzymatic mixture
with H4K20 with the assignment of product cross-peaks. e 1H-13C HSQC data of the enzymatic mixture with H4Kaza20 with the assignment of product
cross-peaks. f 1H-13C HSQC data of the enzymatic mixture with H4Koxy20 with the assignment of product cross-peaks
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SETD8, we synthesized and characterized the H4K20me peptide
by 1D and 2D NMR spectroscopy and compared the spectroscopic
data with the enzymatically produced H4K20me (Supplementary
Figs. 52 and 53). The characteristic proton resonances of chemi-
cally synthesized H4K20me have identical chemical shifts to those
seen for the enzymatically produced species (Supplementary
Fig. 54).
We then performed the analysis of methylation of H4Kaza20
and H4Koxy20 by SETD8. The appearance of new singlet
resonances at 2.48 ppm for H4Kaza20 and 2.55 ppm for H4Koxy20
indicated that SETD8 catalyzed methylation of both lysine
analogs (Fig. 4b, c, respectively). 1H-13C HSQC spectrum
revealed that the 1H resonance at 2.76 ppm (13C: 47.8 ppm) is
H4Kaza20me CH2δ, and the 1H resonance at 2.48 ppm (13C: 35.1
ppm) is NMe of H4Kaza20me (Fig. 4e). The site of methylation
was conﬁrmed by HMBC analysis; NMe resonance at 2.48 ppm
did not show correlation with CH2δ at 47.8 ppm (Supplementary
Fig. 55). A correct coupling network for H4Kaza20me was
supported by TOCSY analysis (Supplementary Fig. 55). 1H-13C
HSQC spectrum showed that the 1H resonance at 3.65 ppm
(13C: 71.9 ppm) is H4Koxy20me CH2δ, and the 1H resonance at
2.55 ppm (13C: 37.6 ppm) is NMe of H4Koxy20me (Fig. 4f). The
NMe resonance at 2.55 ppm did not show correlation with CH2δ
at 71.9 ppm in HMBC spectrum, while the TOCSY spectrum
further supported the coupling network for H4Koxy20me
(Supplementary Fig. 56). The integral ratio between the arginine
CH2δ at 3.11 ppm and the NMe resonance at 2.48 ppm
(H4Kaza20me)/2.55 ppm (H4Koxy20me) was 6:3, whereas the
ratio between arginine CH2δ and SAH-CH2γ at 2.61 ppm was 6:2.
These results suggest that the methylation of H4Kaza20/H4Koxy20
by SETD8 is quantitative and also that the conversion of SAM to
SAH is tightly coupled with the enzymatic process (Supplemen-
tary Figs. 57 and 58).
Next, G9a-catalyzed methylation of H3K9 peptides was
investigated by NMR. We ﬁrst performed the reaction of H3K9
with G9a and SAM. The NMR results of the reaction mixture that
contains G9a (8 μM), the H3K9 peptide (400 μM), and SAM
(2 mM) in Tris-D11 buffer (50 mM, pD 8.0) after 1 h at 37 °C,
largely mirrored the results from experiments using functionally
related GLP (Supplementary Fig. 6a, d, and Supplementary
Fig. 59)25. This observation was further supported by 2D TOCSY
and HMBC analyses (Supplementary Fig. 60). Under the same
conditions, we then investigated the site and level of G9a-
catalyzed methylation of H3Kaza9 and H3Koxy9. 1H NMR
spectrum of the enzymatic reaction of H3Kaza9 showed a new
singlet resonance at 3.25 ppm (9H) and a triplet resonance at 2.61
ppm (2H), which corresponds to SAH-CH2γ. In agreement with
MALDI-TOF MS data, this result implies that H3Kaza9 under-
went trimethylation by G9a (Fig. 5b). The 1H-13C HSQC
spectrum showed chemical shift change observed at 2.98 ppm
(13C: 42.1 ppm, CH2δ), and the 1H resonance at 3.25 ppm (13C:
54.1 ppm, NMe3) derived from H3Kaza9me3 (Fig. 5e). Additional
HMBC and TOCSY analyses conﬁrmed that G9a-catalyzed
trimethylation of Kaza occurs on the terminal amine (Supple-
mentary Fig. 61). The NMR spectrum of G9a-catalyzed methyla-
tion of H3Koxy9 showed a singlet resonance at 2.52 ppm (6H) and
a triplet resonance at 2.61 ppm (2H) (SAH-CH2γ) (Fig. 5c and
Supplementary Fig. 62); in line with MALDI-TOF results, this
observation indicates that H3Koxy9 underwent dimethylation by
G9a. Multiplicity-edited HSQC manifests that the 1H resonance
at 2.52 ppm (13C: 46.6 ppm) is NMe2 of H3Koxy9me2 and the 1H
resonance at 3.65 ppm (13C: 70.4 ppm) is CH2δ of H3Koxy9me2
9 8 7 6 5 4 3 2 1 0
1H (ppm)
1H (ppm)
9 8 7 6 5 4 3 2 1 0
1H (ppm)
9 8 7 6 5 4 3 2 1 0
1H (ppm)
3.0 2.5
1H (ppm)
3.03.5 2.5
1H (ppm)
3.03.5 2.5
1H (ppm)
NMe3
CH2ε
CH2δSAH
NMe3
CH2ε
NMe3
CH2ε
SAH
NMe3 SAH
CH2δ
NMe3
CH2δNMe3
SAH
CH2δ
NMe2
CH2δ
NMe3
SAH
CH2δ
NMe2
SAH
4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
1H (ppm)
4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
1H (ppm)
4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
20
40
60
80
13
C 
(pp
m)
20
40
60
80
13
C 
(pp
m)
20
40
50
30
60
70
80
13
C 
(pp
m)
a b c
d e f
Fig. 5 NMR analyses of G9a-catalyzed methylation. a 1H NMR data and the assignment of indicative resonances of the G9a-catalyzed trimethylation of
H3K9 in the presence of SAM after 1 h at 37 °C. b 1H NMR data of the G9a-catalyzed trimethylation of H3Kaza9. c 1H NMR data of the G9a-catalyzed
dimethylation of H3Koxy9. The zoomed areas are shown in dotted box. d 1H-13C HSQC data of the enzymatic mixture with H3K9 with the assignment of
product cross-peaks. e 1H-13C HSQC data of the enzymatic mixture with H3Kaza9 with the assignment of product cross-peaks. f 1H-13C HSQC data of the
enzymatic mixture with H3Koxy9 with the assignment of product cross-peaks
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(Fig. 5f). HMBC analysis did not show correlation between the
NMe2 resonance at 2.52 ppm and CH2δ at 70.4 ppm, and TOCSY
showed the proper coupling network (Supplementary Fig. 63).
After conﬁrming that H4K20, H4Kaza20, and H4Koxy20
peptides, as well as H3K9, H3Kaza9, and H3Koxy9 peptides,
underwent methylation reaction in the presence of SETD8 and
G9a, respectively, we carried out additional 1H NMR analyses
with histone peptides that bear other six unnatural lysine analogs.
The absence of new characteristic resonances (singlets) in the
spectra of enzymatic reactions with these analogs and a lack of an
indicative triplet for SAH-CH2γ at 2.61 ppm implies that lysine
analogs that bear N-amide, N-guanidine, O-nucleophiles, and
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C-nucleophiles were not methylated in the presence of SETD8 or
G9a (Supplementary Figs. 64–69). Collectively, our NMR
observations indicate that H4K20, H4Kaza20, and H4Koxy20 act
as substrates for SETD8, and that H3K9, H3Kaza9, and H3Koxy9
are substrates for G9a. Other N-, O-, and C-nucleophiles in our
panel of simplest lysine analogs, however, were not methylated by
SETD8 and G9a. It is worth stressing that these NMR ﬁndings are
in complete agreement with results from our MALDI-TOF-based
assays.
Quantum mechanics/molecular mechanics studies. Computer
simulations can provide additional information concerning the
energetic and structural origins of the KMT’s activities on different
lysine analogs. Previous computational studies have shown that
the free-energy barriers for the methyl transfers are the key
determinants for the product speciﬁcity and on whether the
enzymes are active or not for catalyzing certain methylation
processes17. The QM/MM MD and free-energy simulations were
performed for SETD8 (GLP) complexed with H4K20 (H3K9) and
the analogs containing the N-nucleophiles. The free-energy pro-
ﬁles for the ﬁrst, second, and third methylation reactions in
SETD8 involving lysine, methyllysine, and dimethyllysine in his-
tone substrates, respectively, are plotted in Fig. 6a. The general
trend of the free-energy barriers for the SETD8-catalyzed methyl
transfers obtained here is quite similar to that obtained in our
previous study31; i.e., the free-energy barrier increases by about 8
kcal mol−1 in Fig. 6a and by 6.5 kcal mol−1 in the earlier study,
respectively, in going from monomethylation to dimethylation.
Both results suggest that the enzyme is a monomethyltransferase.
Some structural information obtained from the simulations is also
provided here. The average active-site structure of the reactant
complex for the ﬁrst methylation is given in Fig. 6b (Supple-
mentary Fig. 70), which shows that the active-site structure has the
lone pair of electrons on Nε of the target lysine (based on the sp3
hybridization) well aligned with the transferable methyl group of
SAM with a relatively short r(CM···Nε) distance (~ 3.4 Å). Sup-
plementary Fig. 71c shows that, for the reactant complex of the
third methylation, the average distance between Nε and the methyl
group (∼4.4 Å) became signiﬁcantly larger compared to that for
the ﬁrst methylation, and the S–CH3 group of SAM cannot be well
aligned with the lone pair of electrons on Nε for the third methyl
transfer. Thus, the efﬁciency of the corresponding methyl transfer
is likely to be signiﬁcantly compromised. This conclusion is
consistent with the results in Fig. 6a, which shows that the free-
energy proﬁle before reaching the transition state (TS) is shifted to
the left of that of the ﬁrst methylation and that the free-energy
barrier for the third methylation is increased by ~5 kcal mol−1.
The similar discussions can be made for the second methylation
reaction involving the monomethyllysine substrate (Supplemen-
tary Fig. 71a). Figure 6c shows that there is a strengthening for the
interactions with the substrate near the transition state, which may
contribute to lowering the free-energy barrier for the methyl
transfer.
The free-energy proﬁle for the methylation reaction involving
H4Kaza20 in SETD8 is given in Fig. 6d, which shows that the free-
energy proﬁle for the methylation reaction has a free-energy
barrier of 18.0 kcal mol−1. The free-energy proﬁle for the
methylation reaction involving H4Koxy20 in SETD8 is given in
Fig. 6g. Comparison of Fig. 6a, g shows that there is a small
increase in the free-energy barrier (by about 2 kcal mol−1) in
going from K20 to Koxy20 for the ﬁrst methylation reaction.
Although Koxy is an α-nucleophile, this result seems to be
consistent with the fact that the oxygen atom in Koxy20 is more
electronegative than the carbon atom and therefore has a higher
tendency to draw electrons from the neighboring N atom. This
would lead to a decrease of nucleophilicity of NH2 and make it
more difﬁcult to accept the methyl group from SAM. Never-
theless, the increase of the barrier is rather small, and this is
consistent with the enzyme kinetics data given above (Table 1),
which showed that monomethylation reaction can occur for K20,
Kaza20, and Koxy20. Figure 6h shows that the active-site structure
for the reactant complex with Koxy20 is quite similar to that with
K20 (Fig. 6b). For instance, the distances between the methyl
donor (CM) and acceptor (N) are 3.36 Å and 3.37 Å for the cases
involving Koxy20 and K20, respectively, and in both cases the lone
pair of electrons on Nε is well aligned with the methyl group of
SAM. Tyr245 forms a relatively stronger hydrogen bond with the
ε-amino group of Koxy20 (i.e., a hydrogen bond distance of 3.06 Å
compared to 3.20 Å in Fig. 6b). This observation is consistent
with the suggestion that there is a decrease of nucleophilicity for
NH2 (i.e., H may carry a more positive partial charge and be able
to form a stronger hydrogen bond). The structure near the
transition state with Koxy20 (Fig. 6i) is also quite similar to that
with K20 (Fig. 6c). It should be pointed out that the changes of
reactivity measured experimentally or free-energy barriers
determined computationally can be the results of changing
different factors, including, but not limited to, the alternations of
electronic structures among different substrates (leading to
different intrinsic reactivity) and the structural ﬁts of substrates
to the active sites. The free-energy proﬁles for the ﬁrst
methylation reactions involving H4hGln20 (Fig. 6j) and
H4nArg20 in SETD8 (Fig. 6m, Supplementary Fig. 72), respec-
tively, show that the free-energy barriers are very high (e.g.,
43 kcal mol−1 for H4hGln20), suggesting that the methylation
reactions cannot occur for these two substrate analogs, consistent
with the experimental observations.
Fig. 6 Computational analyses on SETD8-catalyzed methylation. a Free-energy (potential of mean force) proﬁles for the ﬁrst, second, and third methylation
reactions in SETD8 involving K, Kme, and Kme2, respectively, as a function of the reaction coordinate [R= r(CM···Sδ) – r(CM···Nε)]; the designation of CM, Sδ,
and Nε is shown in Fig. 6b. First methylation: blue line with a free-energy barrier of 19.4 kcal mol−1; second methylation: gray line with a free-energy barrier of
27.5 kcal mol−1; third methylation: orange line with a free-energy barrier of 24.1 kcal mol−1. b Representative active-site structure of the reactant complex of
SETD8 for the ﬁrst methylation containing SAM and lysine. Non-relevant hydrogen atoms are not shown for clarity. SETD8 is shown in sticks, and SAM and
lysine are in balls and sticks. Some average distances are given in Å. c Representative active-site structure near the transition state of the SETD8 complex for
the ﬁrst methylation of H4K20. d Free-energy proﬁle for the ﬁrst methylation reaction involving H4Kaza20. e Representative active-site structure of the
reactant complex of SETD8 for the ﬁrst methylation containing SAM and H4Kaza20. f Representative active-site structure near the transition state of the
SETD8 complex for the ﬁrst methylation of H4Kaza20. g Free-energy proﬁle for the ﬁrst methylation reaction involving H4Koxy20. h Representative active-
site structure of the reactant complex of SETD8 for the ﬁrst methylation containing SAM and H4Koxy20. i Representative active-site structure near the
transition state of the SETD8 complex for the ﬁrst methylation of H4Koxy20. j Free-energy proﬁles for the ﬁrst methylation reactions involving H4hGln20.
k Representative active-site structure of the reactant complex of SETD8 for the ﬁrst methylation containing SAM and H4hGln20. l Representative active-site
structure near the transition state of the SETD8 complex for the ﬁrst methylation of H4hGln20. m Free-energy proﬁles for the ﬁrst methylation reactions to
Nη1 involving H4nArg20. n Representative active-site structure of the reactant complex of SETD8 for the ﬁrst methylation containing SAM and H4nArg20.
o Representative active-site structure near the transition state of the SETD8 complex for the ﬁrst methylation of H4nArg20
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The free-energy proﬁles for the ﬁrst, second, and third
methylation reactions in GLP involving K, Kme, and Kme2 as
the substrates, respectively, are given in Fig. 7a. The free-energy
barriers for the three methylation reactions are quite similar and
all rather low. For instance, the free-energy barriers of the ﬁrst,
second and third methylation are 17.0, 17.8 and 17.0 kcal mol−1,
respectively. The similar and low free-energy barriers indicate
that all the three methylation reactions occur. The results are
consistent with the experimental observations from this work, but
different from some previous computational investigations. In
our earlier study32, we found that GLP could only produce mono-
and dimethyllysine products. Nevertheless, the earlier simulations
were based on older SCC-DFTB parameters with an empirical
scaling and two different X-ray structures for different methyla-
tion reactions (which might lead to some inconsistency).
Interestingly, the active-site structure for the reactant complex
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of the third methylation (Fig. 7b, Supplementary Fig. 73) seems to
be rather similar to that obtained in the earlier simulations, and
the both structures obtained here and earlier showed that the lone
pair of electrons could not be well aligned with the transferable
methyl group, with an average r(CM···Nε) distance of about
4.1–4.5 Å. The existence of the similar free-energy barriers in
Fig. 7a for all the three methylation reactions in GLP suggests that
some additional transition-state stabilization may exist for the
third methylation reaction (to offset the poor reactant structure
for the third methyl transfer) (Supplementary Fig. 74). Figure 7c
shows the active-site structure near the transition state is
stabilized through strengthening the CH···O interactions as well
as by the presence of cation–π interactions involving F1209 and
Y1124. A similar explanation has been used to understand the
substrate/product speciﬁcities of Suv4–20h2 (ref. 33).
The free-energy proﬁles for the ﬁrst, second, and third
methylation reactions in GLP involving H3Kaza9, H3Kaza9me,
and H3Kaza9me2, respectively, are shown in Fig. 7d; the active-
site structures for the reactant complexes of the second and
third methylation reactions are given in Fig. 7e, f, respectively
(Supplementary Fig. 75). The free-energy barriers for all the
three methylation reactions are similar and rather low
(15.9–17.2 kcal mol−1), indicating that GLP is a trimethyl-
transferase for H3Kaza9, in agreement with the experimental
data. The free-energy proﬁles for the ﬁrst, second, and third
methylation reactions of H3Koxy9 in the presence of GLP are
given in Fig. 7g. While the free-energy barriers for the ﬁrst and
second methylation reactions are close to each other with a
difference of only ~1 kcal mol−1, the barrier for the third
methylation is signiﬁcantly higher (i.e., about 4 kcal mol−1
higher than that of the ﬁrst methylation) (Fig. 7g, Supplemen-
tary Fig. 76). The results support the experimental observations
that GLP can only catalyze mono- and dimethylation of
H3Koxy9. The free-energy proﬁle for the ﬁrst methylation
reaction involving H3hGln9 in GLP is given in Fig. 7j; the
active-site structures for the reactant complex and near-
transition state are shown in Fig. 7k, l, respectively. As
is evident from Fig. 7j, the free-energy barrier is as high as
42 kcal mol−1, implying that the methylation cannot occur on
H3hGln9 in the presence of GLP, in line with our experimental
observations.
Discussion
Understanding the molecular origin of enzyme catalysis that plays
essential roles in human health and disease is important from a
basic molecular perspective as well as from a biomedical per-
spective. Despite ongoing examinations of basic biomolecular
requirements that deﬁne the activity of numerous enzymes, an in-
depth understanding of the underlying chemical mechanisms that
control the enzymatic methylation of lysine and other residues
remains incomplete. Members of SAM-dependent methyl-
transferases represent a widespread and important class of
enzymes that catalyze N-, O-, and C-methylation reactions in all
kingdoms of life34,35. Our work highlights that cooperative
experimental and computational investigations enable the
exploration of the chemical foundation for human KMT-catalyzed
methylation of histones that possess lysine and its simplest analogs
at an unprecedented level of molecular detail. The nucleophilic
character and the basicity of lysine and analogous N-, O-, and C-
nucleophiles as well as the conformations of the substrates at the
active sites appear to deﬁne whether the enzymatic methylation
takes place or not. In comparison with lysine, protonated forms of
Kaza and Koxy are slightly stronger acids that undergo easier
deprotonation by KMTs36,37, but their unprotonated forms are
somewhat poorer nucleophiles than lysine38,39. The nucleophilic
characters and the binding conformations of Kaza and Koxy (as
demonstrated from computer simulations) may therefore con-
tribute to the observations that Kaza and Koxy can in general
undergo the KMT-catalyzed methylation to a similar degree
compared to lysine. The lack of methylation of nArg by KMTs
indicates that the Tyr-rich active sites of KMTs may not have an
ability to deprotonate the weakly acidic guanidinium cation of
nArg and that the electron lone pair of nArg may not be able to
align well with the methyl group of SAM for the methyl transfer.
Thus, the arginine methylation is catalyzed by functionally related
arginine methyltransferases (RMTs) that have different active sites
with well aligned methyl donor and acceptor and containing
negatively charged Glu residues for deprotonating the weakly
acidic guanidinum group of Arg during the methyl transfer pro-
cesses (Supplementary Fig. 77)40,41. Our experimental observa-
tions that KOH does not undergo KMT-catalyzed methylation by
SETD8, G9a, and GLP suggest that deprotonation of the very
poorly acidic hydroxyl group cannot take place in the KMT active
site, thus leading to an inactive substrate (OH is a much poorer
nucleophile than O−)42.
The elucidation of the chemical foundation of epigenetics
remains one of the great challenges of modern biomolecular
sciences. It is envisaged that current chemical biology approa-
ches will contribute to an advanced understanding of biomo-
lecular recognition and enzyme-catalyzed posttranslational
modiﬁcations on histones and other proteins5,9,43–46. Toward
this aim, our integrated synthetic, enzymatic, and computa-
tional studies demonstrate that the biocatalytic scope of bio-
medically important KMTs is limited to N-methylation, and
that the nucleophilic character and related basicity of the
functional group importantly contribute to the efﬁciency of the
enzymatic methylation reaction.
Fig. 7 Computational analyses on GLP-catalyzed methylation. a Free-energy proﬁles for the ﬁrst, second, and third methylation reactions in GLP involving
K, Kme, and Kme2, respectively. The color scheme for the proﬁles is the same as in a. Free-energy barrier of the ﬁrst methylation: 17.0 kcal mol−1; second
methylation: 17.8 kcal mol−1; third methylation: 17.0 kcal mol−1. b Representative active-site structure of the reactant complex of GLP for the third
methylation containing SAM and H3K9me2. Non-relevant hydrogen atoms are not shown here for clarity. c Representative active-site structure near the
transition state of the GLP complex for the third methylation of H3K9me2. d Free-energy proﬁles for the ﬁrst, second, and third methylation reactions in
GLP involving H3Kaza9, H3Kaza9me, and H3Kaza9me2, respectively. Free-energy barrier of the ﬁrst methylation: 15.9 kcal mol−1; second methylation: 17.2
kcal mol−1; third methylation: 16.5 kcal mol−1. e Representative active-site structure of the reactant complex of GLP for the second methylation containing
SAM and H3Kaza9me. f Representative active-site structure of the reactant complex of GLP for the third methylation containing SAM and H3Kaza9me2.
g Free-energy proﬁles for the ﬁrst, second, and third methylation reactions in GLP involving H3Koxy9, H3Koxy9me, and H3Koxy9me2, respectively. Free-
energy barrier of the ﬁrst methylation: 17.5 kcal mol−1; second methylation: 18.8 kcal mol−1; third methylation: 21.3 kcal mol−1. h Representative active-site
structure of the reactant complex of GLP for the second methylation containing SAM and H3Koxy9me. i Representative active-site structure of the reactant
complex of GLP for the third methylation containing SAM and H3Koxy9me2. j Free-energy proﬁle for the ﬁrst methylation reaction involving H3hGln9.
k Representative active-site structure of the reactant complex of GLP for the ﬁrst methylation containing SAM and H3hGln9. l Representative structure
near-transition state of the GLP complex for the ﬁrst methylation of H3hGln9
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Methods
Solid-phase synthesis of histone peptides. Histone peptides bearing lysine and
its analogs were synthesized on Wang resin using Fmoc solid-phase peptide
synthesis (SPPS). Coupling of the amino acids was carried out for 1 h at room
temperature with 3.0 equiv. of the desired amino acid, 3.6 equiv. of 1 M N-
hydroxybenzotriazole (HOBt) in DMF and 3.3 equiv. of N,N′-diisopropylcarbo-
diimide (DIPCDI). Fmoc-protected nucleophilic lysine analogs were coupled
overnight. Deprotection of the Fmoc-groups was carried out with piperidine in
DMF (20%, v/v) for 30 min. After each coupling and deprotection step, a Kaiser
test was done to ensure completion of the reaction. After the ﬁnal Fmoc removal,
the peptides were cleaved from the resin with mild cleaving reagents, to ensure that
the acid-labile protecting groups remained intact. Cleavage was performed by a
mixture of 95% of triﬂuoroacetic acid (TFA), 2.5% Triisopropylsilane (TIS), and
2.5% water for 4 h at room temperature. Crude peptides were puriﬁed by reverse
phase HPLC. Fractions containing the pure peptide were collected, frozen, and
lyophilized to afford the product as a white-off solid. The purity of histone peptides
was examined by analytical HPLC and predicted masses were conﬁrmed by
MALDI-TOF MS, LC–MS, and ESI–MS. Results of characterization of histone
peptides are presented in Supplementary Figs. 3–12.
HPLC and ESI–MS analyses of histone peptides. Lyophilized crude H3 and H4
peptides were puriﬁed by prep-HPLC on a Phenomenex® Gemini-NX 3u C-18
110A reversed-phase column (150 × 21.2 mm) using gradient elution at constant
ﬂow rate of 10 mLmin−1 and the temperature is 30 °C. A typical run for all histone
peptides was performed as follows: C-18 reverse phase column; after 3 mins at 3%
B, a gradient of 3–15% over 12 mins was introduced, followed by a gradient of
15–30% over 17 mins and from 30 to 100% B over 19 mins, proceeding with 100 to
100% over 21 mins ﬁnalized by 3 mins at 100% CH3CN (total runtime 30 mins).
Solvent A is 0.1% TFA in H2O, Solvent B is 0.1% TFA in acetonitrile. The amount
of sample applied to the preparative column was 10–15 mg in 1 mL of MilliQ water
(100 µL injection per each run). The crude peptides samples were ﬁltered through
syringe ﬁlters (0.22 µm, Screening Devices B.V, The Netherlands) prior to injection
onto the column. H3 peptides were eluted at 8–11 min, whereas H4 peptides were
eluted at 15–20 min. Pure fractions containing product were combined, frozen, and
freeze-dried overnight to produce pure histone peptides as a white-off solid.
Lyophilization was achieved using an ilShin Freeze Dryer (ilShin, Ede, The
Netherlands). The puriﬁed peptides were characterized by analytical HPLC,
MALDI–MS, and LC–MS. Analytical HPLC was performed on a Shimadzu LC-
2010A HPLC system (Shimadzu, Kyoto, Japan) using RP C-18 column from
Phenomenex, Prodigy ODS3, particle size 5 µm, pore size 110 Å, length 150 mm,
and internal diameter 4.60 mm. Linear gradients of acetonitrile (+0.1% TFA) into
H2O (+0.1% TFA) were run at 1 mLmin−1 ﬂow rate over 50 min. A peptide
concentration of 1.0 mgmL−1 in milliQ water offered optimal resolution and
separation with the following gradients: After 1 min at 5%, a gradient of 5 to 100%
over 30 min was introduced, followed by 5 min at 100 to 100% and followed by a
gradient of 100 to 5% in 5 min. Histone peptides were detected at 214 nm wave-
length. The retention time of each peptide was shown on the top of the corre-
sponding peak in HPLC chromatogram. The used MilliQ water was puriﬁed using
a WaterPro PS Polisher (Labconco), set to 18.2 MΩ cm−1. Mass spectrometric
analyses of the H3 and H4 peptides were carried out by ESI–MS (Thermo Finnigan
LCQ Advantage Max) operating in a positive ionization mode, which was per-
formed on a Thermo Finnigan LCQ-Fleet ESI-ion trap (Thermoﬁscher, Breda, The
Netherlands) equipped with a Phenomenex Gemini-NX C-18 column, 50 ×
2.0 mm, particle size 3 µM (Phenomenex, Utrecht, The Netherlands). Linear gra-
dients of acetonitrile (+0.1% formic acid) into H2O (+0.1% Formic acid) were run
at 0.2 mLmin−1 ﬂow rate over 50 min. Ions were scanned in a range of m/z
50–2000 in MS mode. Multiply charged molecular-related ions of each peptide
were detected. The observed masses matched the predicted peptide masses which
are summarized in Supplementary Table 2.
Expression and puriﬁcation of the KMTs. The expression and puriﬁcation of
SETD8 (residues 186–352), G9a (residues 913–1193), and GLP (residues
951–1235) were carried out as previously described25. Brieﬂy, the WT enzymes
were recombinantly expressed in E. coli Rosetta BL21 (DE3)pLysS cells, using the
LB broth supplemented with kanamycin and chloramphenicol. The cultures were
induced with isopropyl-D-thiogalactopyranoside (IPTG). Cells were harvested by
centrifugation and lysed, and the expressed proteins were puriﬁed employing Ni-
NTA afﬁnity column and size exclusion chromatography using an AKTA system.
Protein purity was monitored by SDS-PAGE and the concentrations were deter-
mined using the Nanodrop DeNovix DS-11 spectrophotometer.
Methyltransferase activity assays. The standard conditions of methyltransferase
activity assays were performed by MALDI-TOF MS in 50 µL ﬁnal volume for 1 h at
37 °C. Assay conditions for selected KMTs enzymes are described here. For SETD8,
the reaction contained enzyme (2 µM), H4 peptide (GGAKRHRK20VLRDNIQ) or
any of its unnatural analogs (100 µM), SAM (200 µM) in 50 mM Tris-HCl (pH=
8.0). At high concentration and long incubations, SETD8 was (10 µM) and SAM
(1mM). For G9a and GLP, the reaction contained enzyme (2 µM), H3 peptide
(ARTKQTARK9STGGKA) or any of its unnatural analogs (100 µM), excess of
SAM (500 µM) in 50 mM Tris-HCl (pH= 8). At longer incubation time and high
concentration, G9a and GLP were (10 µM) and SAM (1mM). Samples were
incubated in an Eppendorf vial 1.5 mL in thermomixer. An aliquot of the reaction
5 µL was quenched with 5 µL of MeOH to stop the enzymatic reaction before
analysis by MALDI–MS spectra. The spots were placed on a stainless steel MALDI
plate (MS 96 target ground steel BC of Bruker, Germany). The mass spectra were
measured in the positive reﬂector mode using α-cyano-4-hydroxycinnamic acid
matrix. The mass corresponding to one monomethylation was observed as +14 Da,
demethylation was observed as +28 Da, and trimethylation was observed as +42
Da. The MALDI–MS data were annotated employing FlexAnalysis software
(Bruker Daltonics, Germany). Enzymatic assays for methylated substrates were
carried out in ﬁve repeats (distinct samples), whereas for the unmethylated histone
peptides in triplicate (distinct samples). The evaluations applied in this work
directly measure by mass shifts the substrates activity of SETD8, G9a and GLP. It is
noteworthy to mention that in the conditions of MALDI-TOF MS analysis, non-
enzyme and non-SAM controls were carried out to ensure that the conditions of
MS assay did not affect the observable methylation states. Laser power was adjusted
to slightly above the threshold to obtain high resolution and signal/noise ratios.
Each measurement was obtained by accumulating three spectra collected at dif-
ferent positions on the plate, 100 shots per position.
The kinetic assays for SETD8-catalyzed methylation of histone peptides was
carried out employing a MALDI-TOF MS assay to determine the initial velocity
rates for the ﬁrst methylation reaction47. A solution of histone peptide (0–300 μM),
was added to a solution of SAM (3 μM) in assay buffer (50 mM Tris, pH 8.0) at
room temperature (the ﬁnal volume of 100 μL). The reaction was then initiated by
the addition of SETD8 (2 µM) and shaken for 10 min. The enzyme activity was
quickly neutralized by the addition of methanol:water (1:1). The different reaction
mixtures were aliquoted and mixed with α-Cyano-4-hydroxycinnamic acid matrix
prior to measurement. All experiments were carried out in replicates (distinct
samples). The enzymatic activity was determined by taking the peak areas of each
methylation state, including all isotopes and adducts, and is expressed relative to a
control reaction in which no monomethylation is present, utilizing the
FlexAnalysisTM software. Kinetics values were extrapolated by plotting initial
reaction velocities against peptide concentrations, utilizing GraphPad Prism 5.
Methyltransferase inhibition assays. The inhibition assays were performed in
20 µL in Eppendorf vials in triplicates (distinct samples) as previously described48.
Unnatural histone peptide (0–100 µM ﬁnal concentration) was preincubated with
G9a or GLP (100 nM ﬁnal concentration) for 5 min at 37 °C in 18 µL of 50 mM
glycine pH 8.8 containing 2.5% glycerol as assay buffer. The reaction was initiated
by the addition of 2 µL of a pre-mixture of SAM (20 µM ﬁnal concentration of
200 μM stock) and 14-mer histone peptide (5 µM ﬁnal concentration of 100 μM
stock) to afford a ﬁnal reaction volume of 20 µL. The enzymatic reaction was
incubated for an additional 30 min. Then the reaction was quenched with the
addition of 20 µL of MeOH. 2 µL of the quenched reaction was mixed with 2 µL of
matrix solution (5.0 mgmL−1 of α-CHCA in 50% acetonitrile/H2O, 0.1% TFA) and
spotted on the MALDI plate for crystallization. The enzymatic activity was
determined by taking the peak areas of each methylation state, including all iso-
topes and adducts, and is expressed relative to a control reaction in which no
unnatural histone peptide is present, utilizing the FlexAnalysisTM software. The
half maximal inhibitory concentration (IC50) and the drawing curves, and inhi-
bition studies were calculated using nonlinear regression in GraphPad Prism 5.
NMR experiments. For the NMR experiments of SETD8 with H4K20 peptides,
samples (300 µL ﬁnal volume) were prepared containing SETD8 (8 µM), peptide
(400 µM, diluted from a 2mM stock in 50 mM Tris-D11.HCl at pD 8.0, supple-
mented with D2O), SAM (2mM, diluted from a 10mM stock in 50 mM Tris-D11.
HCl at pD 8.0, supplemented with D2O). After incubation for 1 h at 37 °C in an
Eppendorf vial using a thermomixer, the reaction mixture was transferred into the
NMR tube and then diluted to 550 μL with Tris-D11.HCl buffer and recorded by 1H
NMR at 298 K. For the NMR experiments of G9a with H3K9 peptides, similar
conditions were applied. Per each NMR experiment, identical incubation was run
in parallel but without enzyme as a control. NMR spectra were recorded using a
Bruker Avance III-500 MHz magnet equipped with the Prodigy BB cryoprobe.
Water suppression was performed by presaturation and the 1D spectra were
acquired with 128 or 256 transients and a relaxation delay of 4 s. 2D TOCSY
spectra were acquired with presaturation of the water resonance using 1k points
per transient, 8.3 kHz spin-lock for 100 ms, 56 transients per increment with a
relaxation delay of 2 s and 512 increments with a sweep width of 10 ppm in each
dimension. 2D 1H-13C multiplicity-edited HSQC spectra were acquired using 1k
points per transient, 64 transients per increment, a relaxation delay of 2 s, and 512
increments. The 13C sweep width spanned from −10 to 130 ppm. 1H NMR
characterization of substrates prior to enzymatic catalysis was performed using a
30° excitation pulse, 16–128 transients per compound, and a relaxation delay of 8 s.
1H-13C spectra of the substrates were recorded using a 30° excitation pulse,
512–4096 transients per compound and a relaxation delay of 2 s. 1H and 13C
chemical shifts were externally referenced to TMS based on the lock frequency of
solvent. NMR enzymatic experiments were conducted at 310 K. MestreNova was
used to process the 1D and 2D NMR data.
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QM/MM computations. QM/MM-free energy (potential of mean force) and MD
simulations were performed to study the active-site dynamics of SETD8 and GLP
and to calculate the free-energy proﬁles of the methyl transfers from SAM to the
target lysine and lysine analogs containing the N-nucleophiles using the CHARMM
program49. The –CH2–CH2–S+(Me) –CH2– part of SAM and lysine/lysine analog
chain were treated by QM and the rest of the system by MM. The link-atom
approach50 was applied to separate the QM and MM regions. A modiﬁed TIP3P
water model51 was employed for the solvent, and the stochastic boundary mole-
cular dynamics method52 was used for the QM/MM simulations. The reaction
region was a sphere with radius r of 20 Å, and the buffer region extended over 20
Å ≤ r ≤ 22 Å. The reference center for partitioning the system was chosen to be the
Nζ atom of the target lysine or the corresponding atoms in the lysine analogs. The
resulting systems contained around 5800 atoms, including about 700–800 water
molecules. The DFTB3 method52,53 implemented in CHARMM was used for the
QM atoms. The semi-empirical approach adopted here has been used previously
on a number of systems, and the results seem to be quite reasonable54,55. The all-
hydrogen CHARMM potential function (PARAM27)56 was used for the
MM atoms.
The initial coordinates for the reactant complexes of the methylation were based
on the crystallographic complexes (PDB codes: 2BQZ and 3HNA for SETD8 and
GLP, respectively) containing, SAH and methyl lysine (i.e., the product complexes).
In each of the cases, a methyl group was manually added to SAH to change it to
SAM and the methyl group(s) on the methyl lysine were manually deleted to
generate the target lysine. For the models with the lysine analogs, the –CH2–NH3
group on lysine was modiﬁed to change to the corresponding groups on the
analogs. The initial structures for the entire stochastic boundary systems were
optimized using the steepest descent (SD) and adopted-basis Newton–Raphson
(ABNR) methods. The systems were gradually heated from 50.0 to 298.15 K in 50
ps. A 1-fs time step was used for integration of the equation of motion, and the
coordinates were saved every 50 fs for analyses. 1.5 ns QM/MM MD simulations
were carried out for each of the reactant complexes, and the similar approaches
have been used previously17,31–33,57.
The umbrella sampling method58 implemented in the CHARMM program
along with the Weighted Histogram Analysis Method (WHAM)59 was applied to
determine the change of the free energy (potential of mean force) as a function of
the reaction coordinate for the methyl transfer from SAM to the target lysine or
lysine analog in each enzyme. The reaction coordinate was deﬁned as a linear
combination of r(CM-Nε) and r(CM-Sδ) [R= r(CM-Sδ)- r(CM-Nε)] (see Fig. 6b for
the atom designation). Thirty windows were used, and for each window 50 ps
production runs were performed after 50 ps equilibration. The force constants of
the harmonic biasing potentials used in the PMF simulations were 50–400 kcal
mol–1 Å–2.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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